Susan Daimler - Sep 8, 2021 Form 4 Insider Report for ZILLOW GROUP, INC. (ZG)

Signature
/s/ Bradley D. Owens
Stock symbol
ZG
Transactions as of
Sep 8, 2021
Transactions value $
-$1,776,173
Form type
4
Date filed
9/10/2021, 05:52 PM
Previous filing
Jun 3, 2021
Next filing
Dec 10, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ZG Class C Capital Stock Options Exercise $332K +9.36K $35.48 9.36K Sep 8, 2021 By Spouse
transaction ZG Class C Capital Stock Options Exercise $111K +4.95K +52.9% $22.41 14.3K Sep 8, 2021 By Spouse
transaction ZG Class C Capital Stock Options Exercise $316K +9K +62.91% $35.16 23.3K Sep 8, 2021 By Spouse
transaction ZG Class C Capital Stock Sale -$2.22M -23.3K -100% $95.20 0 Sep 8, 2021 By Spouse F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ZG Stock Option (right to buy) Options Exercise $0 -9.36K -80.84% $0.00 2.22K Sep 8, 2021 Class C Capital Stock 9.36K $35.48 By Spouse F2
transaction ZG Stock Option (right to buy) Options Exercise $0 -4.95K -11.11% $0.00 39.6K Sep 8, 2021 Class C Capital Stock 4.95K $22.41 By Spouse F3
transaction ZG Stock Option (right to buy) Options Exercise -$316K -9K -22.22% $35.16 31.5K Sep 8, 2021 Class C Capital Stock 9K $35.16 By Spouse F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported price is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $94.92 to $95.50. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range.
F2 Date at which first vesting occurs is indicated. 1/16th of the total number of shares originally subject to the option becomes vested at the 1st vesting date and an additional 1/192 shall vest each month thereafter over the next 3 years; an additional 1/16th of the total number of shares originally subject to the option becomes vested on the 1-year anniversary of the first vesting date and an additional 1/192 becomes vested each month thereafter over the next 3 years; an additional 1/16th of the total number of shares originally subject to the option becomes vested on the 2-year anniversary of the first vesting date and an additional 1/192 becomes vested each month thereafter over the next 3 years; and an additional 1/16th of the total number of shares originally subject to the option becomes vested on the 3-year anniversary of the first vesting date and an additional 1/192 becomes vested each month thereafter over the next 3 years until the option is fully vested.
F3 Date at which first vesting is indicated. On March 28, 2016, an option for 44,547 shares was granted, of which 29,698 shares subject to the option were fully vested prior to the date of this report, reported on the Form 3 for the reporting individual and, effective March 9, 2021, 14,849 shares were amended to vest as to 1/6th on the first vesting date indicated and as to an additional 1/6th on each issuer quarterly vesting date occurring thereafter until the option is fully vested. The option previously vested based on achievement of annual performance criteria.
F4 Date at which first vesting is indicated. On March 7, 2017, an option for 40,500 shares was granted, of which 13,500 shares subject to the option were fully vested prior to the date of this report, reported on the Form 3 for the reporting individual and, effective March 9, 2021, 27,000 shares were amended to vest as to 1/6th on the first vesting date indicated and as to an additional 1/6th on each issuer quarterly vesting date occurring thereafter until the option is fully vested. The option previously vested based on achievement of annual performance criteria.